Year: 2021
Type: dissertation
Abstract: Efficacy of B-cell depletion therapy highlights the antibody-independent effector functions of B cells in rheumatoid arthritis (RA).Given type 1 helper T (Th1) cells abundant in synovial fluid (SF) of RA, we have determined whether Th1 cells could generate novel effector B cells.Microarray and qPCR analysis identified CXCL9/ 10 transcripts as highly expressed genes upon BCR/CD40/IFN-γ stimulation.Activated Th1 cells promoted the generation of CXCL9/10-producing T-bet + B cells.Expression of CXCL9/10 was most pronounced in CXCR3 + switched memory B cells.Compared with peripheral blood, SFRA enriched highly activated Th1 cells that coexisted with abundant CXCL9/10-producing T-bet + B cells.Intriguingly, anti-IFN-γ antibody and JAK inhibitors significantly abrogated the generation of CXCL9/10-producing T-bet + B cells.B cell derived CXCL9/10 significantly facilitated the migration of CD4 + T cells.These findings suggest that Th1 cells generate the novel CXCL9/10-producing T-bet + effector B cells that could be an ideal pathogenic B cell target for RA therapy.
Author: NAKAYAMA, Tsuyoshi
Institution: Kyushu University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7144891239
